BioCentury
ARTICLE | Company News

Shionogi, Victory Pharma deal

July 25, 2011 7:00 AM UTC

Shionogi will acquire all marketed drugs from Victory Pharma for $118 million in cash, plus up to $9 million in milestones. The deal covers seven pain treatments and two for infectious diseases, including NSAID Naprelan naproxen and anti-infectives Moxatag Amoxicillin Pulsys and Keflex cephalexin. The deal is expected to close as early as July 26. Victory Pharma could not be reached for comment on plans for the company. ...